STAFF INVESTIGATORS: AYTEKIN OTO, M.D.

。根据CCSG之前的审查(2007)、我们外部咨询委员会的建议以及我们的战略规划工作，UCCCC已将扩大基础、临床和翻译成像研究确定为高度优先事项。为了扩大我们的成像研究和改善癌症的临床管理，高级成像计划(AL)进行了重大重组。具体地说，高度重视将成像和成像分析方法整合到临床试验中，以评估新的疗法和造影剂，以及开发和测试新的成像方法。CCSG需要资金支持一名工作人员调查员Aytekin Oto博士，以带头开展这些工作。工作人员调查员将与成像工作组、UCCCC高级领导、现有或正在开发的共享资源以及放射科特定模式实验室密切合作，以促进转译和临床成像研究。

. Based on the previous CCSG review (2007), the recommendations of our External Advisory Committee, and our strategic planning efforts, the UCCCC has identified the expansion of basic, clinical, and translational imaging research as a high priority. To expand our imaging research and improve the clinical management of cancer, the Advanced Imaging Program (Al) has undergone significant restructuring. Specifically, a high priority has been placed on the integration of imaging and imaging analysis methodology into clinical trials to evaluate new therapies and contrast agents, as well as developing and testing new imaging methods. CCSG funds are requested to support one Staff Investigator, Dr. Aytekin Oto, to spearhead these efforts. The Staff Investigator will work closely with the Imaging Working Group, UCCCC senior leaders, and existing or developing Shared Resources, and the Department of Radiology modality-specific laboratories to facilitate translational and clinical imaging research.